Lixte Biotechnology Stock Forward View - Simple Moving Average
| LIXT Stock | USD 2.52 0.00 0.00% |
The successful prediction of Lixte Biotechnology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Lixte Biotechnology Holdings, which may create opportunities for some arbitrage if properly timed.
As of today, the 14-period RSI for Lixte Biotechnology stands at 36, indicating moderately negative momentum. This range suggests moderated price movement without extreme directional pressure.Momentum 0
Sell Peaked
Oversold | Overbought |
This view frames how Lixte Biotechnology Holdings responds to recent headlines and peer activity within its market context.
The Simple Moving Average forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 2.52 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.30.Lixte Biotechnology after-hype prediction price | USD 2.61 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of Lixte Biotechnology to cross-verify projections for Lixte Biotechnology. The view provides historical context for the projection set.Lixte Biotechnology Additional Predictive Modules
Most predictive techniques to examine Lixte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lixte using various technical indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lixte Biotechnology Simple Moving Average Price Forecast For the 11th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 2.52 with a mean absolute deviation of 0.14 , mean absolute percentage error of 0.03 , and the sum of the absolute errors of 8.30 .Please note that although there have been many attempts to predict Lixte Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lixte Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lixte Biotechnology Stock Forecast Pattern
| Backtest Lixte Biotechnology | Lixte Biotechnology Price Prediction | Research Analysis |
Lixte Biotechnology Forecasted Value
This next-day forecast for Lixte Biotechnology Holdings uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Lixte Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Lixte Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.7492 |
| Bias | Arithmetic mean of the errors | 0.0424 |
| MAD | Mean absolute deviation | 0.1384 |
| MAPE | Mean absolute percentage error | 0.0414 |
| SAE | Sum of the absolute errors | 8.301 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion.
Lixte Biotechnology After-Hype Price Density Analysis
As far as predicting the price of Lixte Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Lixte Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Lixte Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lixte Biotechnology's historical news coverage.
Current Value
The after-hype framework applied to Lixte Biotechnology Holdings assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Lixte Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lixte Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lixte Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lixte Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.75 | 4.71 | 0.10 | 0.06 | 9 Events | 5 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.52 | 2.61 | 3.57 |
|
Lixte Biotechnology Hype Timeline
Lixte Biotechnology is now traded for 2.52. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of -0.06. Lixte is forecasted to increase in value after the next headline, with the price projected to jump to 2.61 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 3.57%, whereas the daily expected return is now at -0.75%. The volatility of related hype on Lixte Biotechnology is about 6116.88%, with the expected price after the next announcement by competition of 2.46. Lixte Biotechnology Holdings currently holds 318.28 K in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Use Historical Fundamental Analysis of Lixte Biotechnology to cross-verify projections for Lixte Biotechnology. The view provides historical context for the projection set.Lixte Biotechnology Related Hype Analysis
Having access to credible news sources related to Lixte Biotechnology's direct competition is more important than ever and may enhance your ability to predict Lixte Biotechnology's future price movements. Getting to know how Lixte Biotechnology's peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KAPA | Kairos Pharma | -0.09 | 6 per month | 0.00 | -0.05 | 10.26 | -8.24 | 29.57 | |
| LEXX | Lexaria Bioscience Corp | -0.04 | 9 per month | 0.00 | -0.01 | 10.61 | -9.68 | 42.53 | |
| ALLR | Allarity Therapeutics | -0.07 | 5 per month | 4.30 | 0.02 | 8.43 | -7.29 | 29.05 | |
| CING | Cingulate | 0.02 | 5 per month | 3.89 | 0.19 | 8.45 | -6.53 | 24.88 | |
| BCTX | Briacell Therapeutics Corp | -1.04 | 7 per month | 0.00 | -0.07 | 8.72 | -8.84 | 98.43 | |
| PULM | Pulmatrix | -0.03 | 7 per month | 0.00 | -0.11 | 8.98 | -9.35 | 52.45 | |
| ENTO | Entero Therapeutics | 0.09 | 5 per month | 0.00 | -0.01 | 16.86 | -17.06 | 39.61 | |
| HOTH | Hoth Therapeutics | -0.01 | 8 per month | 0.00 | -0.05 | 6.17 | -4.55 | 14.39 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | -0.27 | 7.96 | -17.54 | 83.67 | |
| CASI | CASI Pharmaceuticals | 0.04 | 8 per month | 0.00 | -0.13 | 11.90 | -8.51 | 98.17 |
Other Forecasting Options for Lixte Biotechnology
For every potential investor in Lixte, whether a beginner or expert, Lixte Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Lixte Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lixte Biotechnology stock to make a market-neutral strategy. Peer analysis of Lixte Biotechnology could also be used in its relative valuation, which is a method of valuing Lixte Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lixte Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on.
| Accumulation Distribution | 5899.99 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.51 | |||
| Day Typical Price | 2.52 | |||
| Price Action Indicator | 0.005 | |||
| Relative Strength Index | 36.32 |
Lixte Biotechnology Risk Indicators
The analysis of Lixte Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lixte Biotechnology's investment and either accepting that risk or mitigating it.
| Mean Deviation | 3.49 | |||
| Standard Deviation | 4.64 | |||
| Variance | 21.5 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lixte Biotechnology
Coverage intensity for Lixte Biotechnology Holdings matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Lixte Biotechnology Short Properties
Short sentiment tied to Lixte Biotechnology Holdings matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 1 M |
Additional Tools for Lixte Stock Analysis
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |